AU2001229646A1 - Method of identifying the function of a test agent - Google Patents
Method of identifying the function of a test agentInfo
- Publication number
- AU2001229646A1 AU2001229646A1 AU2001229646A AU2964601A AU2001229646A1 AU 2001229646 A1 AU2001229646 A1 AU 2001229646A1 AU 2001229646 A AU2001229646 A AU 2001229646A AU 2964601 A AU2964601 A AU 2964601A AU 2001229646 A1 AU2001229646 A1 AU 2001229646A1
- Authority
- AU
- Australia
- Prior art keywords
- identifying
- function
- test agent
- test
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17741600P | 2000-01-21 | 2000-01-21 | |
US60177416 | 2000-01-21 | ||
USNOTGIVEN | 2000-12-07 | ||
PCT/US2001/001838 WO2001053534A2 (en) | 2000-01-21 | 2001-01-19 | Method of identifying the function of a test agent |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001229646A1 true AU2001229646A1 (en) | 2001-07-31 |
Family
ID=22648513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001229646A Abandoned AU2001229646A1 (en) | 2000-01-21 | 2001-01-19 | Method of identifying the function of a test agent |
Country Status (3)
Country | Link |
---|---|
US (1) | US20010046665A1 (en) |
AU (1) | AU2001229646A1 (en) |
WO (1) | WO2001053534A2 (en) |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3852004T2 (en) * | 1987-04-15 | 1995-06-01 | Yissum Res Dev Co | METHOD FOR DETERMINING THE EXPRESSION OF BIOREGULATORY GENES IN MICROCULTURES OF EUCARIONTIC CELLS. |
EP0534640B1 (en) * | 1991-09-23 | 1996-10-02 | Pfizer Inc. | Process for detecting specific mRNA and DNA in cells |
US5985829A (en) * | 1994-12-19 | 1999-11-16 | The United States Of America As Represented By The Department Of Health And Human Services | Screening assays for compounds that cause apoptosis and related compounds |
US5955269A (en) * | 1996-06-20 | 1999-09-21 | Rutgers, The State University Of New Jersey | Methods of screening foods for nutraceuticals |
US5804436A (en) * | 1996-08-02 | 1998-09-08 | Axiom Biotechnologies, Inc. | Apparatus and method for real-time measurement of cellular response |
US6008014A (en) * | 1996-09-04 | 1999-12-28 | Millennium Pharmaceuticals, Inc. | Method of making lipid metabolic pathway compositions |
WO1999050401A1 (en) * | 1998-03-27 | 1999-10-07 | Helix Research Institute | Method for detecting change in gene expression by treating with test compound |
US6146830A (en) * | 1998-09-23 | 2000-11-14 | Rosetta Inpharmatics, Inc. | Method for determining the presence of a number of primary targets of a drug |
US6479241B1 (en) * | 1999-09-10 | 2002-11-12 | Southern Research Institute | High throughput screening of the effects of anti-cancer agents on expression of cancer related genes in various cell lines |
-
2001
- 2001-01-19 WO PCT/US2001/001838 patent/WO2001053534A2/en active Application Filing
- 2001-01-19 AU AU2001229646A patent/AU2001229646A1/en not_active Abandoned
- 2001-01-19 US US09/766,863 patent/US20010046665A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001053534A3 (en) | 2002-04-18 |
WO2001053534A2 (en) | 2001-07-26 |
US20010046665A1 (en) | 2001-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002212258A1 (en) | Assembly and method for the optical-tactile measurement of a structure | |
AU2002232386A1 (en) | A method for testing a light-emitting panel and the components therein | |
AU2002225956A1 (en) | Automated test protocol | |
EP1154276B8 (en) | Testing head for microstructures | |
AU2001263887A1 (en) | Monitoring method | |
AU2001250686A1 (en) | Method and device for testing a well | |
AUPQ886100A0 (en) | Diagnostic test | |
AUPQ687600A0 (en) | A method of detection | |
AU2001253917A1 (en) | Fluid testing apparatus | |
AU2001282185A1 (en) | Testing a transceiver | |
AU2001281633A1 (en) | Detection method | |
AU2001275007A1 (en) | Methods of testing materials | |
AU2002231295A1 (en) | Developed seed and methods for making the same | |
AU2001254959A1 (en) | Test signalling | |
AU3584101A (en) | Test apparatus | |
AU2001272273A1 (en) | Laser-ultrasonic testing system | |
AUPR050700A0 (en) | Detection method | |
AU3717601A (en) | Ultrasonic testing | |
AUPQ667800A0 (en) | Detection method | |
AU2001278135A1 (en) | Method of identifying immunosuppressive agents | |
AU2001237530A1 (en) | Method | |
GB0012992D0 (en) | Test method | |
AU2001236968A1 (en) | Lssd interface | |
AU2002246912A1 (en) | Receptor-binding compounds and methods for identifying them | |
AU2001241636A1 (en) | Halotherapy method |